Robert Deans

Robert Deans

Company: Bluerock Therapeutics

Job title: CIO


Dr Deans is Chief of Innovation at BlueRock Therapeutics, a biotechnology company creating next generation cell therapeutics by harnessing pluripotent stem cell biology and gene editing tools. BlueRock is developing allogeneic cell therapeutics for the blood, brain and heart.  Prior to BlueRock, Dr Deans was CSO at Rubius Therapeutics developing a platform of novel enucleated cell therapeutics based on engineering and expansion of hematopoietic progenitors to mature reticulocytes.  Dr. Deans has more than 25 years of experience in adult stem cell therapeutics which includes stem cells from bone marrow including both hematopoietic gene therapies as well as mesenchymal stromal cell (MSC) populations.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.